Financial Daily from THE HINDU group of publications
Thursday, Feb 21, 2002

News
Features
Stocks
Port Info
Archives

Group Sites

Agri-Biz & Commodities - Bio-tech & Genetics
Corporate - Alliances & Joint Ventures
Marketing - Strategy


OmegaTech, Vasta in marketing pact

Our Bureau

CHENNAI, Feb. 20.

THE US-based OmegaTech Inc, a biotech R&D company, has entered into a marketing agreement with Vasta Marketing, Chennai, to market DHA Gold, a long chain fatty acid applicable as a nutrition supplement and food additive with beneficial health properties.

According to Mr Jan Haakonsen, General Manager, Asia-Pacific Operations, OmegaTech, DHA is a long chain omega-3 fatty acid derived from a marine algae, and has wide ranging clinically-proved health benefits. The product is docosahexaenoic acid obtained from cultured marine algae, schizochytrium sp, through a patented technology developed by OmegaTech, he said.

Vasta Marketing, as an ingredient supplier, will import the algae in dried powder form and as oil extracted from the algae, according to Mr S.N. Srikanth, Director, Vasta Markting. These will be available in bulk packs for supply to a wide range of industries including manufacturers of pharmaceuticals and neutraceuticals, baby foods, processed foods and animal feeds. The algae powder can be used to enrich animal feeds.

The oil can be used to make gel capsules or added to a wide range of food products to enhance nutritional value.

Send this article to Friends by E-Mail

Stories in this Section
Apeda plans big to boost mango abroad


Thirsty days are here again
Rubber down on poor demand
e-nabling TN rice farmers
OmegaTech, Vasta in marketing pact
ICAR fingers crossed on Karnal bunt-free crop
Workshop on crop cultivation costs
Farming technology fills in for child labour


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | Home |

Copyright 2002, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line